As of September 1st, 2024, 16% of the 2024 calendar year allocation of Open Access fee-waived articles remains for Elsevier.
The Elsevier deal has a maximum number of articles per year that may be published as Open Access under this agreement. When the 2024 calendar year limit is reached, corresponding authors will no longer see the option to publish Open Access at no charge during their article publishing process. Corresponding authors have two options: 1) they can choose to publish Open Access on their own and pay the APC, or 2) if they are submitting to a hybrid journal, they can choose to publish the article under the traditional subscription access model at no charge.
OhioLINK has negotiated an upgraded agreement that offers open-access publishing benefits. Starting in January 2024 and continuing through the end of 2027, authors at participating OhioLINK member institutions now have the ability to publish open access (OA) journal articles in most of Elsevier’s hybrid journals at no additional cost to either the author or the institution. Some journals are excluded from open-access publishing benefits, such as Cell Press and Lancet journals.
Author queries: oasupport@elsevier.com